Jan 27 (Reuters) - Dr Martens PLC DOCS.L:
Q3 FY26 TRADING STATEMENT
ON TRACK FOR SIGNIFICANT PROFIT GROWTH IN FY26
EMEA MARKET CONTINUES TO BE CHALLENGING, WITH OUR DTC REVENUE PERFORMANCE IMPACTED
Q3 GROUP REVENUE DOWN 2.7% TO £253M
WE ARE COMFORTABLE WITH MARKET EXPECTATIONS FOR FY26 PBT
NOW EXPECT £15M HEADWIND TO FY GROUP REVENUE AND BROADLY NEUTRAL IMPACT ON ADJUSTED PBT
FOR FY26 AS A WHOLE WE EXPECT REVENUE ON A CONSTANT CURRENCY BASIS TO BE BROADLY FLAT
Source text: ID:nRSa4163Qa
Further company coverage: DOCS.L
((Reuters.Briefs@thomsonreuters.com;))